Europe Injectable Drug Delivery Market 2019-2027 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Europe Injectable Drug Delivery Market 2019-2027” report has been added to ResearchAndMarkets.com’s offering.

MARKET OUTLOOK

A new report states that the injectable drug delivery market in Europe is progressing at a CAGR of 7.50% during the forecast period 2019-2027.

The United Kingdom, France, Italy, Russia, Germany, Spain and the Rest of Europe comprise the injectable drug delivery market in Europe.

The increase in the elderly age group population and the growing prevalence of chronic diseases will proliferate the market of injectable delivery drug technology in Europe.

The growth of the injectable drug delivery system market in France can be owed to the increasing number of pharmaceutical companies that are engaged in the development of drug delivery technologies. The vigorous R&D activities is another important factor driving the market. As per the European Federation of Pharmaceutical Industries and Association, about 30 pharmaceutical organizations are indulged in the advancement of drug delivery technologies in France. These companies are making huge investments in developing enhanced and better quality drug administration technologies. The increasing demand for the generics on these pharmaceutical companies is expected to boost the market growth in the country.

Due to the increasing smoking habit among Italian women, lung cancer is very prevalent in the female population of the country. Besides, a high number of cases of tumors in the pancreas and thyroid are also observed. These factors, along with the growing pharmaceutical sector, are expected to instigate the market growth of injectable drug delivery systems in Italy. (Read more…)

Key Topics Covered:

1. Europe Injectable Drug Delivery Market – Summary

2. Industry Outlook

2.1. Market Definitions

2.2. Porter’s Five Forces Model

2.3. Market Share Outlook

2.4. Key Insight

2.5. Key Buying Criteria

2.6. Legal Requirement

2.7. Regulatory Framework

2.8. Market Attractiveness Index

2.9. Market Drivers

2.10. Market Restraint

2.11. Market Opportunity

2.12. Market Challenges

3. Injectable Drug Delivery Market Outlook – by Device Type

3.1. Pen Injector

3.2. Auto Injector

3.3. Needle-Free Injector

3.4. Prefilled Syringe

4. Injectable Drug Delivery Market Outlook – by Route of Administration

4.1. Subcutaneous

4.2. Intramuscular

4.3. Intravenous (Iv)

4.4. Other Route of Administration

5. Injectable Drug Delivery Market Outlook – by End-User

5.1. Clinics/ Physician Offices

5.2. Ambulatory Care

5.3. Hospital

5.4. Home Based

5.5. Others End-User

6. Injectable Drug Delivery Market – Europe

6.1. Country Analysis

6.1.1. the United Kingdom

6.1.2. Germany

6.1.3. France

6.1.4. Italy

6.1.5. Spain

6.1.6. Russia

6.1.7. Rest of Europe

7. Company Profiles

7.1. Baxter

7.2. Becton, Dickinson and Company (BD)

7.3. Elcam Medical

7.4. Eli Lilly and Company

7.5. Gerresheimer

7.6. Injex

7.7. Novartis AG

7.8. Novo Nordisk A/S

7.9. Pfizer Inc

7.10. Sanofi

7.11. Schott AG

7.12. Terumo Corporation

7.13. Teva Pharmaceutical Industries Ltd

7.14. West Pharmaceutical Services Inc

7.15. Ypsomed

8. Research Methodology & Scope

8.1. Research Scope & Deliverables

8.1.1. Objectives of Study

8.1.2. Scope of Study

8.2. Sources of Data

8.2.1. Primary Data Sources

8.2.2. Secondary Data Sources

8.3. Research Methodology

8.3.1. Evaluation of Proposed Market

8.3.2. Identification of Data Sources

8.3.3. Assessment of Market Determinants

8.3.4. Data Collection

8.3.5. Data Validation & Analysis

For more information about this report visit https://www.researchandmarkets.com/r/kzn7dc

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900